Sarcopenia: revised European consensus on definition and diagnosis
By A. Cruz-Jentoft, G. Bahat, J. Bauer, Y. Boirie, O. Bruyère, T. Cederholm, Chris Cooper, F. Landi, Y. Rolland, A. Sayer and 19 more. Age and Ageing, 2018
11,542 citations recorded by the source corpus.
Abstract Background in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Subfields: Geriatrics and Gerontology, Physiology
View Paper: https://www.semanticscholar.org/paper/ccbd36e412f2f03b0db9d7628ea646fb57c093c9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Geriatrics and Gerontology
- Luigi Ferrucci
- J. Morley
- L. Fried
- Emiel Hoogendijk
- O. Theou
- E. Dent
- Arnold Mitnitski
- Kenneth Rockwood
In Physiology
- Luigi Ferrucci
- J. Morley
- L. Fried
- Stephen B. Kritchevsky
- Arnold Mitnitski
- Kenneth Rockwood
- M. F. Holick
Citations in the corpus
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review (2023, background): “102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
- International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management (2018, neutral): “…tool for sarcopenia, but this was voted out in the consensus process for two main reasons: (i) the new EWGSOP guidelines for sarcopenia [EWGSOP-2 (59)] recommend that grip strength is a diagnostic assessment rather than a screening test; and (ii) the specific feedback we received from the…”
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2021, background): “1,2,6 In this study, a comprehensive systematic review of the published literature was performed, and data were extracted for the estimation of the overall prevalence of sarcopenia and severe sarcopenia.”
- International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines (2021, positive): “Sarcopenia (the loss of muscle mass, strength, and function with ageing) requires high-intensity resistance training for optimal adaptation, demonstrating the clear need to consider both modality and intensity when addressing this pervasive disease (29).”
- World guidelines for falls prevention and management for older adults: a global initiative (2022, neutral): “International clinical practice guidelines exist for the screening, diagnosis and management of sar-copenia [244, 245].”
- Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management (2019, background): “Physical frailty is also related to sarcopenia [low muscle strength and/or muscle quantity of quality] (45-48), with clinical management of the two conditions overlapping somewhat (33, 49).”